Prostatic Artery Embolization (PAE) for Symptomatic Benign Prostatic Hyperplasia (BPH): Part 2, Insights into the...

Area of Science:

• Urology
• Interventional Radiology
• Cell Biology

Background:

• Benign prostatic hyperplasia (BPH) affects millions of men, leading to lower urinary tract symptoms.
• Current treatments for BPH include medication and surgery, but these have limitations.
• Prostatic artery embolization (PAE) is an emerging minimally invasive treatment for BPH.

Purpose of the Study:

• To review and elucidate the underlying mechanisms of prostatic artery embolization (PAE) in treating symptomatic benign prostatic hyperplasia (BPH).
• To explore novel insights into PAE's therapeutic effects beyond conventional understanding.
• To highlight potential new treatment strategies and techniques based on a deeper understanding of PAE mechanisms.

Main Methods:

• Literature review of studies investigating PAE mechanisms.
• Analysis of evidence for ischemia-induced apoptosis in the prostate.
• Examination of the role of androgen circulation, denervation, and nitric oxide pathways in PAE.

Main Results:

• PAE induces prostate gland shrinkage via ischemic infarction.
• Novel mechanisms include ischemia-induced apoptosis and enhanced apoptosis due to androgen circulation blockage.
• Secondary denervation and the nitric oxide pathway may also contribute to PAE's therapeutic effects.

Conclusions:

• The mechanisms of PAE for BPH are more complex than previously thought.
• Understanding these mechanisms can lead to improved PAE techniques and patient outcomes.
• Further research into PAE's cellular and molecular effects is warranted.